Intrinsic Value

The intrinsic value of Sequana Medical NV (SEQUA) under the Base Case is 1.018 EUR per share. Compared with the current market price of 0.611 EUR, the stock appears Undervalued by 40% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

SEQUA Intrinsic Value
€1.018
Undervaluation 40%
Intrinsic Value
Price €0.611

SEQUA is cheaper than usual. It was this cheap or cheaper on just 15% of days in the past 5 years.

Alert me when SEQUA is below its intrinsic value
Today €0.611 · 0.0% below the current price
Alternatives to SEQUA

Fundamental Analysis

What Sequana Medical Does

Health Care

Sequana Medical makes implantable medical devices that help remove unwanted fluid from the body. Its best-known product is the alfapump, a small pump system that moves excess abdominal fluid out of the body in patients with severe liver disease and related fluid buildup. The company is also developing other treatments for fluid overload, including therapies aimed at heart failure patients.

Headquarters
Belgium BE
Employees
48
IPO date
Feb 11, 2019
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue SEQUA Research

Decided on Sequana Medical? Get an email when SEQUA reaches the price you’d buy at. Free with an account.

Other Sequana Medical listings

What is the Intrinsic Value of one SEQUA stock?

The intrinsic value for Sequana Medical NV (SEQUA) under the Base Case is 1.018 EUR.

Is SEQUA stock undervalued or overvalued?

Compared with the current market price of 0.611 EUR, the stock appears Undervalued by 40% .

How reliable are our estimates? See how past valuations played out
Back to Top